Dosing Intervals of Darbepoetin Alfa May Be Extended in Pre-Dialysis Patients - Renal and Urology News PDF Print
Renal and Urology News
LAS VEGAS—Darbepoetin alfa dosing intervals in pre-dialysis patients with chronic kidney disease (CKD) may be extended beyond the approved one- or two-week frequency, researchers reported at the National Kidney Foundation's Spring Clinical Meetings.

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.